| First Author | Roh YS | Year | 2018 |
| Journal | Am J Pathol | Volume | 188 |
| Issue | 11 | Pages | 2574-2588 |
| PubMed ID | 30125542 | Mgi Jnum | J:270509 |
| Mgi Id | MGI:6276437 | Doi | 10.1016/j.ajpath.2018.07.011 |
| Citation | Roh YS, et al. (2018) Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice. Am J Pathol 188(11):2574-2588 |
| abstractText | Toll-like receptor 7 (TLR7) signaling regulates the production of type 1 interferons (IFNs) and proinflammatory cytokines, such as tumor necrosis factor (TNF)-alpha, implicated in the control of regulatory T (Treg) cell activity. However, the mechanistic interplay between TLR7 signaling and Treg cells in nonalcoholic steatohepatitis (NASH) has not been elucidated. Our aim was to clarify the role of TLR7 signaling in the pathogenesis of NASH. Steatohepatitis was induced in wild-type (WT), TLR7-deficient, IFN-alpha/beta receptor 1-deficient, and Treg cell-depleted mice. TLR7-deficient and IFN-alpha/beta receptor 1-deficient mice were more protective to steatohepatitis than WT mice. Of interest, both TNF-alpha and type 1 IFN promoted apoptosis of Treg cells involved in the prevention of NASH. Indeed, Treg cell-depleted mice had aggravated steatohepatitis compared with WT mice. Finally, treatment with immunoregulatory sequence 661, an antagonist of TLR7, efficiently ameliorated NASH in vivo. These results demonstrate that TLR7 signaling can induce TNF-alpha production in Kupffer cells and type I IFN production in dendritic cells. These cytokines subsequently induce hepatocyte death and inhibit Treg cells activities, leading to the progression of NASH. Thus, manipulating the TLR7-Treg cell axis might be used as a novel therapeutic strategy to treat NASH. |
